Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 23,063,409
- Share change
- +19,428,234
- Total reported value
- $90,576,655
- Price per share
- $4.02
- Number of holders
- 29
- Value change
- +$76,545,252
- Number of buys
- 19
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13D/G
13F
|
Company |
20%
|
9,392,275
|
$35,502,800 | +$30,394,980 | 22 Dec 2025 | |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
10%
|
8,591,572
|
$32,476,142 | $0 | 23 Dec 2025 | |
| Logos Global Management LP |
13D/G
|
— |
9.9%
|
4,435,444
|
$18,407,093 | $0 | 23 Dec 2025 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
10%
|
4,539,854
|
$18,250,213 | $0 | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
|
— |
10%
|
4,330,315
|
$17,970,807 | $0 | 31 Dec 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
6.4%
|
2,838,000
|
$11,777,700 | $0 | 31 Dec 2025 | |
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,275,000
|
$4,794,000 | — | 27 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
252,029
|
$534,302 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.26%
|
116,500
|
$245,234 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
75,625
|
$160,357 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.16%
|
72,669
|
$152,968 | — | 30 Sep 2025 | |
| Apella Capital, LLC |
13F
|
Company |
0.09%
|
39,314
|
$99,484 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
17,416
|
$36,000 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
16,519
|
$35,020 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.03%
|
12,406
|
$26,115 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
11,008
|
$23,172 | — | 30 Sep 2025 | |
| Rangeley Capital, LLC |
13F
|
Company |
0.02%
|
10,000
|
$21,050 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,430
|
$5,000 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,341
|
$2,823 | — | 30 Sep 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
420
|
$1,000 | — | 30 Sep 2025 | |
| Groupe la Francaise |
13F
|
Individual |
0%
|
337
|
$603 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
162
|
$341 | — | 30 Sep 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
100
|
$211 | — | 30 Sep 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$211 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
62
|
$131 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
50
|
$106 | — | 30 Sep 2025 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
12
|
$25 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
10
|
$21 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
3/4/5
|
Company · 10%+ Owner |
0%
|
1
|
$2 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Sep 2025 | |
| Remy Luthringer |
3/4/5
|
CEO, Director |
—
class O/S missing
|
2,250,000
|
— | — | 22 Dec 2025 | |
| Boehringer AG |
13D/G
|
— |
3.4%
|
1,500,225
|
— | $0 | 23 Dec 2025 | |
| Geoff Race |
3/4/5
|
President |
—
class O/S missing
|
1,500,000
|
— | — | 22 Dec 2025 | |
| Frederick W. Ahlholm |
3/4/5
|
SVP, CFO and Secretary |
—
class O/S missing
|
500,000
|
— | — | 22 Dec 2025 | |
| David Kupfer |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| Fouzia Laghrissi-Thode |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| Hans Peter Hasler |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| VAN HEEK G JAN |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| Jeryl L. Hilleman |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 27 Sep 2023 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q4 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.